Statistics for Zymeworks (id:7923 ZYME)

Valuation metrics

Market cap

1.03B

Enterprise value

783.10M

Trailing P/E (ttm)

3.79

Forward P/E

-8.88

PEG ratio

-8.88

Price/Sales (ttm)

16.51

Price/Book (mrq)

2.83

Enterprise Value/Revenue

12.59

Enterprise Value/EBITDA

-6.83

Overview

Shares outstanding

68.88M

Float

41.16M

Shares short

4.70M

% Held by insiders

0.00%

% Held by institutions

0.98%

Average volume (10 days)

561.16K

Average volume (90 days)

Price summary

52-Week low

7.97

52-Week high

17.70

52-Week change

40.48%

Beta

1.16

50-Day moving average

13.51

200-Day moving average

10.89

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-182.75%

Operating margin

-213.78%

Operational effectiveness

Return on assets

-14.69%

Return on equity

-28.73%

Income statement

Revenue (ttm)

0.83

Revenue per share (ttm)

0.83

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-114,707,000.00

Net income to common (ttm)

-113,671,000.00

Diluted EPS (ttm)

-1.49

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

297.20M

Total cash per share (mrq)

4.32

Total debt (mrq)

20.28M

Total Debt/Equity (mrq)

5.53

Current ratio (mrq)

409.70%

Book value per share (mrq)

5.27

Cash flow

Cash flow statement

-54,582,000.00

Levered free cash flow (LFCF)

-9,535,625.00